ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,142Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 761

$491K Total Retail Price of All Prescriptions

Rank: 134 out of 761

373 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 7,195 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 586 425 1 3
SIMVASTATIN 388 316 2 2
FUROSEMIDE 312 294 3 7
HYDROCHLOROTHIAZIDE 261 206 4 11
LISINOPRIL 249 214 5 1
GABAPENTIN 228 164 6 15
AMLODIPINE BESYLATE 226 188 7 6
WARFARIN SODIUM 218 217 8 9
HYDROCODONE-ACETAMINOPHEN 173 113 S3 9 5
POTASSIUM CHLORIDE 170 130 10 18
LOSARTAN POTASSIUM 165 144 11 13
METOPROLOL SUCCINATE 164 146 12 16
LOVASTATIN 158 107 13 17
ATENOLOL 156 125 14 8
METOPROLOL TARTRATE 153 139 15 14
OMEPRAZOLE 146 89 16 4
CITALOPRAM HBR 146 103 16 19
METFORMIN HCL 139 110 18 10
TRAZODONE HCL 122 63 19 23
ATORVASTATIN CALCIUM 116 104 20 12
DONEPEZIL HCL 100 86 21 33
NAMENDA 100 94 21 59
PANTOPRAZOLE SODIUM 99 76 23 40
SERTRALINE HCL 96 92 24 25
PAROXETINE HCL 92 68 25 47
CYMBALTA 90 62 26 53
CEPHALEXIN 88 63 27 145
ALENDRONATE SODIUM 79 74 28 21
FENTANYL 77 59 S2 29 57
METHYLDOPA 76 60 R 30 287
FLUTICASONE PROPIONATE 74 63 31 29
AMITRIPTYLINE HCL 74 59 R 31 54
BENICAR 70 58 33 81
OXYBUTYNIN CHLORIDE ER 70 62 33 137
OXYCODONE HCL 69 63 S2 35 24
ALLOPURINOL 63 50 36 28
PREDNISONE 60 55 37 30
ROPINIROLE HCL 58 50 38 95
SYNTHROID 58 45 38 64
BUPROPION HCL SR 58 17 38 93
LIDODERM 57 51 41 163
CLOPIDOGREL 52 47 42 66
TRAMADOL HCL 51 37 43 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.